Evolent Health (EVH) | Financial Analysis & Statements

Evolent Health Inc. | Small-cap | Healthcare

$11.64

-1.27%

Evolent Health vs Veeva Systems Evolent Health vs Ge Healthcare Evolent Health vs Premier Evolent Health vs Certara Evolent Health vs Schrodinger Evolent Health vs S&P 500 | Market

Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 2.6B

Gross Profit 367.4M 14.38%

Operating Income -14.1M -0.55%

Net Income -61.6M -2.41%

EPS (Diluted) -$0.81

Balance Sheet Metrics

Total Assets 2.5B

Total Liabilities 1.5B

Shareholders Equity 1.0B

Debt to Equity 1.54

Cash Flow Metrics

Operating Cash Flow 55.1M

Free Cash Flow -6.1M

Revenue & Profitability Trend

Evolent Health Income Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Revenue	2.6B	2.0B	1.4B	908.0M	924.6M
Cost of Goods Sold	2.2B	1.5B	1.0B	657.6M	696.6M
Gross Profit	367.4M	460.5M	316.6M	250.4M	228.1M
Operating Expenses	263.0M	358.1M	269.3M	219.5M	210.4M
Operating Income	-14.1M	-21.1M	-19.9M	-29.1M	-43.2M
Pre-tax Income	-63.0M	-202.4M	-62.1M	-29.8M	-330.5M
Income Tax	-1.4M	-89.4M	-43.4M	483.0K	-2.4M
Net Income	-61.6M	-113.0M	-19.2M	-37.6M	-334.2M
EPS (Diluted)	-$0.81	-$1.28	-$0.20	-$0.44	-$3.94

Income Statement Trend

Evolent Health Balance Sheet From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Assets
Current Assets	607.1M	683.7M	478.1M	524.0M	547.6M
Non-Current Assets	1.9B	2.0B	1.3B	895.5M	824.1M
Total Assets	2.5B	2.7B	1.8B	1.4B	1.4B
Liabilities
Current Liabilities	715.5M	674.2M	433.4M	445.5M	403.3M
Non-Current Liabilities	827.7M	938.4M	524.4M	280.3M	348.8M
Total Liabilities	1.5B	1.6B	957.9M	725.8M	752.1M
Equity
Total Shareholders Equity	1.0B	1.1B	859.4M	693.6M	619.6M

Balance Sheet Composition

Evolent Health Cash Flow Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Operating Activities
Net Income	-61.6M	-113.0M	-19.2M	-37.6M	-334.2M
Operating Cash Flow	55.1M	79.7M	12.0M	30.6M	-289.3M
Investing Activities
Capital Expenditures	-	-	-38.4M	-25.0M	-29.5M
Investing Cash Flow	-38.0M	-386.8M	-259.1M	-15.8M	261.1M
Financing Activities
Dividends Paid	-20.1M	-18.8M	-14.9M	-1.3M	-20.0M
Financing Cash Flow	-4.0M	268.8M	127.1M	-42.8M	-14.4M
Free Cash Flow	-6.1M	113.8M	-49.9M	13.8M	-45.7M

Cash Flow Trend

Evolent Health Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -12.96

Forward P/E 7.34

Price to Book 1.30

Price to Sales 0.51

PEG Ratio 7.34

Profitability Ratios

Profit Margin -4.54%

Operating Margin 0.35%

Return on Equity -9.24%

Return on Assets -0.04%

Financial Health

Current Ratio 0.98

Debt to Equity 77.09

Beta 0.88

Per Share Data

EPS (TTM) -$1.22

Book Value per Share $8.08

Revenue per Share $20.86

Peer Financial Comparison

Company	Market Cap	P/E Ratio	P/B Ratio	ROE	Profit Margin	Debt/Equity
evh	1.2B	-12.96	1.30	-9.24%	-4.54%	77.09
Veeva Systems	46.0B	59.92	7.39	14.06%	27.34%	1.24
Ge Healthcare	32.6B	14.95	3.55	26.44%	11.03%	97.52
Premier	1.9B	21.46	1.18	6.85%	4.96%	19.35
Certara	1.7B	104.00	1.56	-0.25%	-0.67%	28.51
Schrodinger	1.5B	44.39	4.05	-43.33%	-83.39%	31.15

Financial data is updated regularly. All figures are in the company's reporting currency.